📰 Clinical Development News
Page 59 - Clinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.
December 3, 2023
Exonate, an mRNA therapy company focused on treatments for diabetic complications, has announced that its lead ophthalmology asset, EXN407, has achieved its prespecified endpoints in an early study.
December 1, 2023
The first six companies enter the Deep Tech Lab - Quantum start-up accelerator at BioInnovation Institute (BII) to unlock the potential in quantum science
December 1, 2023
/PRNewswire/ -- The "DUPIXENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.coms offering. DUPIXENTs potential as a...
December 1, 2023
DUBLIN, Dec. 1, 2023 /PRNewswire/ -- The "DUPIXENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. DUPIXENT's potential as a game-changer extends
November 30, 2023
Professor Deborah Ashby, interim Dean of the Faculty of Medicine, Imperial College, delivered this year’s Sally Hollis Memorial Lecture. OSP enjoyed a discussion with both her and Professor Jennifer Visser-Rogers, vice-president for statistical research and consultancy at Phastar, about how new approaches to clinical trials are changing data monitoring committees.
November 30, 2023
/PRNewswire/ -- The "Metronidazole Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.coms offering. This report provides...
November 30, 2023
Exonate, an mRNA therapy company focused on treatments for diabetic complications, has announced that its lead ophthalmology asset, EXN407, has achieved its prespecified endpoints in an early study.
November 30, 2023
Using a combination of pre-existing HIV drugs, a medicine for HIV-negative people taken before sex has reduced the chances of getting the virus by 86% and considerably reduced HIV contraction in real-world situations across several years of use.
November 29, 2023
– Product development focused on the production of powder formulations of oat beta glucan and avenanthramides for cosmeceuticals market – Technology...
November 29, 2023
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo...